Skip to content

Study · Non-randomized trial · n = 112 · 2014

3 results

[Efficacy of сerebrolysin in acute ischemic stroke].

Petrova OP, Chuprasov AV, Matveev NV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2014

PMID25726802 (opens in a new tab)DOI10.17116/jnevro201411412243-45 (opens in a new tab)PepBankPUB-25726802
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In acute ischemic stroke patients, Cerebrolysin treatment was associated with significantly earlier recovery versus standard treatment only.

    In plain wordsIn acute ischemic stroke patients, recovery occurred earlier with Cerebrolysin than with standard treatment only.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableRecovery
    Study

    n = 112

    Comparator
    Standard treatment only
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    30 ml daily · 10 daysAs given in this study (human).

    Measurements

    P value for earlier recovery
    < 0.05 unitless
    Earlier recovery: cerebrolysin plus standard treatment versus standard treatment only

    Source sentences

    Summary
    A significantly earlier recovery (p<0,05) and decrease in disability were identified.
    1 context sentence
    Summary · context
    The 1st group consisited of 23 patients who received standard treatment and cerebrolysin, the 2nd group included 89 patients who received standard treatment only.
  2. 02HumanNon-randomized trialEfficacy outcome

    In acute ischemic stroke patients, Cerebrolysin treatment was associated with decreased disability versus standard treatment only.

    In plain wordsIn acute ischemic stroke patients, disability decreased with Cerebrolysin compared with standard treatment only.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseDisability
    Study

    n = 112

    Comparator
    Standard treatment only
    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    30 ml daily · 10 daysAs given in this study (human).

    Source sentences

    Summary
    A significantly earlier recovery (p<0,05) and decrease in disability were identified.
    1 context sentence
    Summary · context
    The 1st group consisited of 23 patients who received standard treatment and cerebrolysin, the 2nd group included 89 patients who received standard treatment only.
  3. 03HumanNon-randomized trialEfficacy outcome

    In acute ischemic stroke patients, the Cerebrolysin treatment effect was more pronounced in young patients and with early treatment.

    In plain wordsIn acute ischemic stroke patients, Cerebrolysin's effect was greater in young patients and with early treatment.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableTreatment effect by age and treatment timing
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    30 ml daily · 10 daysAs given in this study (human).

    Source sentences

    Summary
    A more pronounced effect was seen in young patinets and when treatment started early.
    1 context sentence
    Summary · context
    The 1st group consisited of 23 patients who received standard treatment and cerebrolysin, the 2nd group included 89 patients who received standard treatment only.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.